CompoAtlas

Formule Nutrition des cheveux - Shou wu mei fa wan

Food supplement declared in France, declaration No 2023-11-1110

Formule Nutrition des cheveux - Shou wu mei fa wan (Laboratoire Calebasse) is a food supplement declared in France. Status: earlier declaration, replaced by the 2025 declaration. Main ingredients: Reynoutria multiflora 1,800 mg per day, Crataegus laevigata 600 mg per day, Glycine max. 600 mg per day, Lycium barbarum 600 mg per day, Morus alba 600 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Laboratoire Calebasse
Food business operator placing the product on the market
Calebasse
Status
Earlier declaration, replaced by the 2025 declaration : Formule Nutrition des cheveux - Shou wu mei fa wan
Form
Powder
Daily dose
6g
Directions for use
1 dosette équivaut à 1,5g la dosette rase,2 dosettes matin et soir équivaut à 6g
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking diabetes medication, Prolonged use
Objectives stated by the manufacturer (these are not authorised claims)
Hair and nails

Declaration 312467, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Reynoutria multiflora (Thunb.) MoldenkeRootDry aqueous extract1,800 mg
Crataegus laevigata (Poir.) DC.FruitDry aqueous extract600 mg
Glycine max. (L.) Merr.SeedDry aqueous extract600 mg
Lycium barbarum L.FruitDry aqueous extract600 mg
Morus alba L.FruitDry aqueous extract600 mg
Saposhnikovia divaricata (Turcz.) SchischkRootDry aqueous extract600 mg
Sesamum indicum L.SeedDry aqueous extract600 mg
Zingiber officinale RoscoeRhizomeDry aqueous extract600 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin ou votre pharmacien en cas d’usage concomitant de traitement contre le diabète. Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. Pas d'utilisation prolongée sans avis médical.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

  • Glycine max. (L.) Merr.
    Read the warning, when it applies and the studies cited
  • Zingiber officinale Roscoe
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Laboratoire Calebasse

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line